Optimization of the Targeted Anticancer Therapies
The study includes an observational pharmacokinetic study and an interventional medication adherence study. The purpose of this study is 1) to describe the concentration-time profiles of targeted anticancer drugs and to characterize the concentration-effect/toxicity relationships in the target population of patients (o
| Condition(s) | Cancer |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The study includes an observational pharmacokinetic study and an interventional medication adherence study. The purpose of this study is 1) to describe the concentration-time profiles of targeted anticancer drugs and to characterize the concentration-effect/toxicity relationships in the target population of patients (observational study) and 2) to characterize patterns of adherence to oral targeted anticancer drugs and identify key-driver modifiable adherence factors in patients participating in an adherence program (interventional study). |
| Who can participate | Inclusion Criteria: * Cancer patients to whom a targeted anticancer therapy is prescribed Exclusion Criteria: * Patients incapable of judgment or participants under tutelage |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Centre Hospitalier Universitaire Vaudois |
| Locations | Lausanne, Canton of Vaud, Switzerland |
| Start date | 2015-05 |
| NCT ID | NCT04484064 |
| Official listing | https://clinicaltrials.gov/study/NCT04484064 |